These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3705969)

  • 1. Does dihydroergotamine reduce plasma volume?
    Bergqvist D; Lindblad B
    Acta Pharmacol Toxicol (Copenh); 1986 Feb; 58(2):144-7. PubMed ID: 3705969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of dihydroergotamine (DHE) on blood volume and circulation in the calf in peridural anesthesia in the human].
    Stühmeier KD; Stanton-Hicks M; Arndt JO
    Reg Anaesth; 1987 Oct; 10(4):109-13. PubMed ID: 3685475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between the venoconstrictor activity of dihydroergotamine and its pharmacokinetics during acute and chronic oral dosing.
    de Marées H; Welzel D; de Marées A; Klotz U; Tiedjen KU; Knaup G
    Eur J Clin Pharmacol; 1986; 30(6):685-9. PubMed ID: 3533566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of the prostanoid system in mediating the haemodynamic effects of dihydroergotamine.
    Bergqvist D; Lindblad B
    Ups J Med Sci; 1984; 89(3):227-32. PubMed ID: 6516064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydroergotamine decreases the blood content in the skeletal musculature but etilefrine hydrochloride in the splanchnic region in man.
    Arndt JO; Höck A; Inoue K
    Basic Res Cardiol; 1984; 79(2):244-52. PubMed ID: 6146305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dihydroergotamine on cerebral circulation during experimental intracranial hypertension.
    Nilsson F; Messeter K; Grände PO; Rosén I; Ryding E; Nordström CH
    Acta Anaesthesiol Scand; 1995 Oct; 39(7):916-21. PubMed ID: 8848892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular response to spinal anaesthesia in elderly men: effects of head-up tilt and dihydroergotamine administration.
    Bergenwald L; Freyschuss U; Kaijser L; Westermark L
    Clin Physiol; 1981 Oct; 1(5):453-60. PubMed ID: 7199992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dihydroergotamine: discrepancy between arterial, arteriolar and pharmacokinetic data.
    de Hoon JN; Poppe KA; Thijssen HH; Struijker-Boudier HA; Van Bortel LM
    Br J Clin Pharmacol; 2001 Jul; 52(1):45-51. PubMed ID: 11453889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central haemodynamic effects of dextran 70, dihydroergotamine and their combination. A study in dogs.
    Lindblad B; Bergqvist D
    Acta Chir Scand; 1983; 149(5):459-65. PubMed ID: 6195855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dihydroergotamine on perpheral circulation during epidural anaesthesia in man.
    Castenfors J; Lindblad LE; Mortasawi A
    Acta Anaesthesiol Scand; 1975; 19(1):79-84. PubMed ID: 1136694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydroergotamine as a pharmacologic euglycemic clamp in the surgically traumatized rabbit.
    Mossberg KA; Taegtmeyer H
    Metabolism; 1991 Jun; 40(6):594-9. PubMed ID: 1865822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Venoconstrictor effects of dihydroergotamine after intranasal and intramuscular administration.
    Aellig WH; Rosenthaler J
    Eur J Clin Pharmacol; 1986; 30(5):581-4. PubMed ID: 3758146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydroergotamine in idiopathic orthostatic hypotension: short-term intramuscular and long-term oral therapy.
    Fouad FM; Tarazi RC; Bravo EL
    Clin Pharmacol Ther; 1981 Dec; 30(6):782-9. PubMed ID: 7030580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of dihydroergotamine on blood circulation in man in conditions of orthostasis].
    Modin AIu; Abrosimov SV; Anashkin OD; Zhidkov VV; Lobachik VI
    Kosm Biol Aviakosm Med; 1984; 18(3):19-23. PubMed ID: 6737977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological actions of the main metabolites of dihydroergotamine.
    Müller-Schweinitzer E
    Eur J Clin Pharmacol; 1984; 26(6):699-705. PubMed ID: 6489409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo pharmacodynamic interactions between two drugs used in orthostatic hypotension--midodrine and dihydroergotamine.
    Jourdan G; Verwaerde P; Pathak A; Tran MA; Montastruc JL; Senard JM
    Fundam Clin Pharmacol; 2007 Feb; 21(1):45-53. PubMed ID: 17227444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Influence of dihydroergotamine and leg compression on the blood volume in different regions of the body (author's transl)].
    Mostbeck A; Partsch H
    Med Klin; 1978 May; 73(21):801-6. PubMed ID: 651770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of dihydroergotamine on venous distensibility and blood pressure in idiopathic orthostatic hypotension.
    Bellamy GR; Hunyor SN
    Aust N Z J Med; 1984 Apr; 14(2):157-9. PubMed ID: 6591908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Venous tonus-modifying effect, pharmacokinetics and undesired effects of dihydroergotamine].
    Barthel W
    Z Gesamte Inn Med; 1984 Sep; 39(17):417-28. PubMed ID: 6390997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability of dihydroergotamine in man.
    Little PJ; Jennings GL; Skews H; Bobik A
    Br J Clin Pharmacol; 1982 Jun; 13(6):785-90. PubMed ID: 7093108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.